Apolipoprotein Erelated blood pressure parameters in senile dementia. R. Cacabelos, X.A. Alvarez, M. Alcaraz, R. Mouzo, V.M. Pichel.
Ann. Psychiatry.,
1999
Ref: 7:93-97
Changes in brain hemodynamic parameters associated with disease staging and apolipoprotein E genotyping in patients with senile dementia. R. Cacabelos, X.A. Alvarez, P. Pérez, M. Laredo, A. Hernández, J. Figueroa, V.M. Pichel, J.M. Caamaño.
Ann. Psychiatry.,
1999
Ref: 7:87-92
Brain electrical activity mapping, disease staging and apolipoprotein E genotyping in senile dementia. R. Cacabelos, X.A. Alvarez, P. Pérez, M. Laredo, V. Pichel.
Ann.Psychiatry.,
1999
Ref: 7:77-85
Psychometric evaluation and apolipoprotein E genotyping in senile dementia. R. Cacabelos, X.A. Alvarez, P. Pérez, M. Laredo.
Ann. Psychiatry.,
1999
Ref: 7:67-75
Association of genetic risk factors in Alzheimer´s disease. R. Cacabelos, L. Fernández-Novoa, M.D. Mesa.
Ann. Psychiatry,
1999
Ref: 7:35-45
The search for new health care models, integrated treatments and prevention for dementia. R. Cacabelos.
Ann. Psychiatry.,
1999
Ref: 7:xvii-xx
Effects of cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures. R. Cacabelos, V.R.M. Lombardi, M. Windisch, M. García.
Meth. Find. Exp. Clin. Pharmacol.,
1999
Ref: 21:331-338
The glutamatergic system and neurodegeneration in dementia: Preventive strategies in Alzheimer´s disease. R. Cacabelos, M. Takeda, B. Winblad.
Int. J. Geriat. Psychiatry.,
1999
Ref: 14:3-47
E-SAR-94010: A marine fish extract obtained by advanced biotechnological methods. R. Cacabelos, V.R.M. Lombardi.
Drugs Future.,
1999
Ref: 24:167-176
19/20 kDa low molecular weight serum protein pattern: a novel potential biochemical prognostic marker for different types of dementia. R. Cacabelos, V.R.M. Lombardi.
Neurosci. Lett.,
1999
